Compare drug alternatives
Inpefa® Alternatives
Inpefa®(sotagliflozin) | Farxiga®(dapagliflozin) |
---|---|
Prescription Only | Prescription Only |
Dosage & Administration | |
Administration | |
Dosing | |
Latin Shorthand | |
Financial Assistance | |
Out-Of-Pocket Costs With Copay Card | |
$10. Learn more. | $0. Learn more. |
Annual Cap | |
$2,600. Learn more. | $175 per month. Learn more. |
Assistance Expiration | |
12/31/25. Learn more. | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
Physician Advisory | |
Adverse Reactions | |
Most common adverse reactions (incidence ≥ 5%) are urinary tract infection,
volume depletion, diarrhea, and hypoglycemia. . Learn more. | Most common adverse reactions (5% or greater incidence) were female genital
mycotic infections, nasopharyngitis, and urinary tract infections. . Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | SGLT2 Inhibitors. Learn more. |
Special Populations | |
Popular Alternatives
- Inpefa® vs Victoza®
- Inpefa® vs Trulicity®
- Inpefa® vs Xultophy®
- Inpefa® vs Soliqua®
- Inpefa® vs Ozempic®
- Inpefa® vs Rybelsus®
- Inpefa® vs Mounjaro®
- Inpefa® vs Bydureon®
- Inpefa® vs Invokamet®
- Inpefa® vs Invokamet®
- Inpefa® vs Invokana®
- Inpefa® vs Glyxambi®
- Inpefa® vs Jardiance®
- Inpefa® vs Synjardy®
- Inpefa® vs Trijardy XR®
- Inpefa® vs Segluromet®
- Inpefa® vs Steglatro®
- Inpefa® vs Steglujan®